Related Experiment Video
Updated: May 13, 2026

Modeling Paracrine Noncanonical Wnt Signaling In Vitro
Published on: December 10, 2021
WNT signaling determines tumorigenicity and function of ESC-derived retinal progenitors
1Key Laboratory of Stem Cell Biology, Institute of Health Sciences, Shanghai Jiao Tong University School of Medicine, Shanghai, People's Republic of China.
Abstract:
Tumor formation constitutes a major obstacle to the clinical application of embryonic stem cell-derived (ESC-derived) cells. In an attempt to find major extracellular signaling and intrinsic factors controlling tumorigenicity and therapeutic functionality of transplanted ESC-derived retinal progenitor cells (ESC-RPCs), we evaluated multiple kinds of ESC-RPCs in a mouse retinal degeneration model and conducted genome-wide gene expression profiling. We identified canonical WNT signaling as a critical determinant for the tumorigenicity and therapeutic function of ESC-RPCs. The function of WNT signaling is primarily mediated by TCF7, which directly induces expression of Sox2 and Nestin. Inhibition of WNT signaling, overexpression of dominant-negative Tcf7, and silencing Tcf7, Sox2, or Nestin all resulted in drastically reduced tumor formation and substantially improved retinal integration and visual preservation in mice. These results demonstrate that the WNT signaling cascade plays a critical role in modulating the tumorigenicity and functionality of ESC-derived progenitors.
Insights
Embryonic stem cell-derived retinal progenitor cells (ESC-RPCs) can form tumors. Inhibiting WNT signaling, a key pathway, reduces tumor formation and improves cell therapy outcomes in retinal degeneration models.
Area of Science:
- Stem cell biology
- Regenerative medicine
- Ophthalmology
Background:
- Tumor formation is a significant barrier to using embryonic stem cell-derived (ESC-derived) cells in clinical settings.
- ESC-derived retinal progenitor cells (ESC-RPCs) hold promise for treating retinal degeneration but face tumorigenicity challenges.
Purpose of the Study:
- To identify key extracellular signaling and intrinsic factors governing the tumorigenicity and therapeutic function of transplanted ESC-RPCs.
- To investigate the role of WNT signaling in ESC-RPC behavior.
Main Methods:
- Evaluation of various ESC-RPCs in a mouse model of retinal degeneration.
- Genome-wide gene expression profiling to identify critical factors.
- Manipulation of WNT signaling pathway components (inhibition, dominant-negative Tcf7, gene silencing).
Main Results:
- Canonical WNT signaling was identified as a critical determinant of ESC-RPC tumorigenicity and therapeutic function.
- TCF7 mediates WNT signaling, directly inducing Sox2 and Nestin expression.
- Inhibition of WNT signaling or TCF7, Sox2, or Nestin significantly reduced tumor formation.
- Reduced tumorigenicity correlated with improved retinal integration and visual function preservation.
Conclusions:
- The WNT signaling pathway is a critical regulator of both tumorigenicity and therapeutic functionality in ESC-derived progenitors.
- Targeting the WNT/TCF7/Sox2/Nestin axis offers a strategy to enhance the safety and efficacy of ESC-RPC-based therapies.
More Related Videos
Related Concept Videos
Canonical Wnt Signaling Pathway
Canonical Wnt Signaling Pathway
Non-Canonical Wnt Signaling Pathways
Non-Canonical Wnt Signaling Pathways
Role Of Notch Signalling In Intestinal Stem Cell Renewal
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal
